Tsutomu Takeuchi

Suggest Changes
Learn More
OBJECTIVES To evaluate the safety and efficacy of 5-year, long-term tocilizumab monotherapy for patients with rheumatoid arthritis. METHODS In an open-label, long-term extension trial following an(More)
We investigated the clinical efficacy and safety of tocilizumab (a humanized anti-IL-6 receptor antibody) monotherapy in active rheumatoid arthritis (RA) patients with an inadequate response to low(More)